Bone Biologics Corp. (BBLG)
NASDAQ:BBLG
US Market
Holding BBLG?
Track your performance easily

Bone Biologics (BBLG) Financial Statements

60 Followers

Bone Biologics Financial Overview

Bone Biologics's market cap is currently ―. The company's EPS TTM is $-9.781; its P/E ratio is -0.13; Bone Biologics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -783.73K$ 940.85K$ -1.16M$ -2.08M$ -1.77M
EBITDA$ -783.73K$ 940.85K$ -1.16M$ -2.08M$ -1.77M
Net Income Common Stockholders$ -783.73K$ -900.00K$ -1.55M$ -1.92M$ -1.77M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.30M$ 3.20M$ 3.00M$ 4.50M$ 7.00M
Total Assets$ 3.19M$ 3.84M$ 3.74M$ 4.98M$ 7.62M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -2.30M$ -3.20M$ -3.00M$ -4.50M$ -7.00M
Total Liabilities$ 284.51K$ 164.63K$ 831.40K$ 1.18M$ 1.93M
Stockholders Equity$ 2.91M$ 3.67M$ 2.91M$ 3.79M$ 5.69M
Cash Flow-
Free Cash Flow$ -900.00K$ -1.30M$ -2.02M$ -2.56M$ -3.63M
Operating Cash Flow$ -900.00K$ -1.30M$ -2.02M$ -2.56M$ -3.63M
Investing Cash Flow-----
Financing Cash Flow$ 299.00$ 1.50M$ 592.00K-$ 4.45M
Currency in USD

Bone Biologics Earnings and Revenue History

Bone Biologics Debt to Assets

Bone Biologics Cash Flow

Bone Biologics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis